Stemedica Stem Cells Approved For Clinical Trials In Mexico For Chronic Heart ... PR Web (press release) ... Inc. announced today that its strategic partner in Mexico, Grupo Angeles Health Services, has received approval from Mexico's regulatory agency, COFEPRIS, for a Phase I/II single-blind randomized clinical trial for chronic heart failure. |
